Proposed Mechanism BPC-157 appears to work through multiple pathways: Maintaining vesicular integrity (affecting VMATs and dopamine transporters) Possibly occupying its own vesicular storage sites Competing for dopamine receptor binding Functionally substituting when dopaminergic neurons are lost This last property, essentially filling in for missing dopamine function, would explain why the peptide counteracts both receptor agonists (apomorphine) and antagonists (haloperidol, fluphenazine, clozapine, sulpiride) with equal effectiveness
Watson AJ, Bruhn H, MacLeod K, McDonald A, McPherson G, Kilonzo M, Norrie J, Loudon MA, McCormack K, Buckley B, Brown S, Curran F, Jayne D, Rajagopal R, Cook JA
There is extensive published research on GLP-1/GIP medicines in weight-management settings
Over 4 to 6 draws from a single vial, you can lose 0.2 to 0.4mL of solution, which at 10mg/mL represents 2 to 4mg of tirzepatide
Stay Social With Us
Patients utilizing this regenerative protocol frequently report that it: Accelerates the healing of muscles, tendons, and torn ligaments